UMP Healthcare Holdings Limited (HKG:0722)
Hong Kong · Delayed Price · Currency is HKD 0.4750
+0.0100 (2.15%)
At close: Feb 13, 2026
UMP Healthcare Holdings Income Statement
Financials in millions HKD. Fiscal year is July - June.
Millions HKD. Fiscal year is Jul - Jun.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Operating Revenue | 726.95 | 748.49 | 727.17 | 665.86 | 616.36 |
Other Revenue | 0.41 | 1.52 | 0.58 | 0.34 | 0.8 |
| 727.36 | 750.01 | 727.75 | 666.2 | 617.16 | |
Revenue Growth (YoY) | -3.02% | 3.06% | 9.24% | 7.95% | 10.44% |
Cost of Revenue | 236.75 | 253.28 | 225.06 | 202.25 | 160.89 |
Gross Profit | 490.61 | 496.73 | 502.69 | 463.95 | 456.28 |
Selling, General & Admin | 272.38 | 287.54 | 269.44 | 249.11 | 227.77 |
Other Operating Expenses | 74.93 | 69.37 | 59.74 | 60.41 | 53.73 |
Operating Expenses | 453.12 | 470.7 | 433.07 | 388.14 | 352.55 |
Operating Income | 37.49 | 26.03 | 69.62 | 75.81 | 103.73 |
Interest Expense | -7.35 | -6.94 | -5.68 | -3.92 | -3.22 |
Interest & Investment Income | 5.48 | 8.21 | 8.42 | 3.73 | 3.36 |
Earnings From Equity Investments | -0.46 | -0.63 | -4.28 | -1.63 | 0.08 |
Other Non Operating Income (Expenses) | 2.67 | 21.31 | 5.19 | 1.96 | 2.06 |
EBT Excluding Unusual Items | 37.84 | 47.98 | 73.27 | 75.96 | 106.01 |
Merger & Restructuring Charges | - | - | - | - | -0.02 |
Impairment of Goodwill | - | - | - | - | -20.02 |
Gain (Loss) on Sale of Investments | 2.66 | 1.89 | 0.92 | 9.98 | 1.76 |
Gain (Loss) on Sale of Assets | - | - | - | 0.04 | 2.61 |
Asset Writedown | - | -9.24 | -9.82 | - | - |
Pretax Income | 40.5 | 40.62 | 64.37 | 85.98 | 90.36 |
Income Tax Expense | 8.58 | 5.41 | 8.63 | 11.95 | 19.78 |
Earnings From Continuing Operations | 31.92 | 35.22 | 55.74 | 74.03 | 70.58 |
Earnings From Discontinued Operations | - | - | - | 1.2 | -39.04 |
Net Income to Company | 31.92 | 35.22 | 55.74 | 75.23 | 31.54 |
Minority Interest in Earnings | -0.48 | 5.43 | 4.72 | -3.06 | 3.3 |
Net Income | 31.44 | 40.64 | 60.45 | 72.17 | 34.83 |
Net Income to Common | 31.44 | 40.64 | 60.45 | 72.17 | 34.83 |
Net Income Growth | -22.64% | -32.77% | -16.23% | 107.18% | -40.87% |
Shares Outstanding (Basic) | 789 | 799 | 790 | 773 | 761 |
Shares Outstanding (Diluted) | 789 | 799 | 790 | 773 | 761 |
Shares Change (YoY) | -1.28% | 1.21% | 2.17% | 1.61% | 0.24% |
EPS (Basic) | 0.04 | 0.05 | 0.08 | 0.09 | 0.05 |
EPS (Diluted) | 0.04 | 0.05 | 0.08 | 0.09 | 0.05 |
EPS Growth | -21.65% | -33.60% | -17.43% | 102.38% | -41.01% |
Free Cash Flow | 140.34 | 91.54 | 80.71 | 26.4 | 149.17 |
Free Cash Flow Per Share | 0.18 | 0.11 | 0.10 | 0.03 | 0.20 |
Dividend Per Share | 0.033 | 0.033 | 0.047 | 0.045 | 0.038 |
Dividend Growth | - | -29.79% | 4.44% | 18.42% | 15.15% |
Gross Margin | 67.45% | 66.23% | 69.07% | 69.64% | 73.93% |
Operating Margin | 5.16% | 3.47% | 9.57% | 11.38% | 16.81% |
Profit Margin | 4.32% | 5.42% | 8.31% | 10.83% | 5.64% |
Free Cash Flow Margin | 19.29% | 12.21% | 11.09% | 3.96% | 24.17% |
EBITDA | 81.91 | 68.78 | 103.82 | 101.73 | 127.31 |
EBITDA Margin | 11.26% | 9.17% | 14.27% | 15.27% | 20.63% |
D&A For EBITDA | 44.41 | 42.75 | 34.2 | 25.92 | 23.58 |
EBIT | 37.49 | 26.03 | 69.62 | 75.81 | 103.73 |
EBIT Margin | 5.15% | 3.47% | 9.57% | 11.38% | 16.81% |
Effective Tax Rate | 21.19% | 13.31% | 13.41% | 13.89% | 21.89% |
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.